Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 376 for “"Pharmaceutical industry"”.
-
Outsourcing research in the pharmaceutical industry
Thesis (M.S.)--Massachusetts Institute of Technology, Sloan School of Management, 1995.
-
Corporate Social Responsibility in the Pharmaceutical Industry
… corporate social responsibility (CSR) in the pharmaceutical industry is essential for both society at large and the pharmaceutical business in general. I support this hypothesis with data from pharmaceutical businesses that have CSR programs and explain how these programs can help in multiple …
-
Pharmaceutical Industry Events and the Stock Market
… to three significant events relevant to the pharmaceutical drug pricing issue in the United States. We examine a few policies and solutions in e↵orts to assist with this issue. Using an event study methodology, we investigate the impact of the Generic Drug User Fee Act of 2012 (GDUFA) and …
-
Economics of innovation in the pharmaceutical industry
… the economics of innovation in the healthcare industry. In Chapter 2 I use a global data set to measure the effect of health losses and average patient income on innovation in different therapeutic areas. I show that the average patient income is a strong predictor of the number of clinical …
-
Product Innovation in the United States Pharmaceutical Industry
Made available in DSpace on 2014-12-09T17:52:33Z (GMT). No. of bitstreams: 1 6406046.pdf: 13619638 bytes, checksum: 41fbd66baa6bdad54455db4b9cc799d5 (MD5) Previous issue date: 1963
-
Financial Analysis of the Pharmaceutical Industry, 1930-1959
Made available in DSpace on 2014-12-05T20:11:25Z (GMT). No. of bitstreams: 1 6104264.pdf: 6125186 bytes, checksum: f33d9ec431a13e560f89af23497eae1d (MD5) Previous issue date: 1961
-
Machine-assisted synthesis and development in pharmaceutical industry
Machine-assisted synthesis and development in pharmaceutical industry Perman Jorayev Process development of novel chemical transformations is often a laborious and complex task. This is mostly due to the difficulties in identifying the underlying reaction mechanism(s), selection of chemical …
-
eBusiness technologies and trends in the pharmaceutical industry
… the defacto business model of many firms. The pharmaceutical industry will continue to thrive regardless of recession, terrorism, war, or other external forces. Question is: what eBusiness technologies and trends are being currently pursued by pharmaceutical companies in managing critical …
-
Essays in the industrial organization of the pharmaceutical industry
… issues in the industrial organization of the pharmaceutical industry. In the first chapter, I study the effects of television advertising of antidepressants using a novel method comparing households near the borders of television markets. I find that advertising has positive benefits on the …
-
Optimizing the planning of IBC usage in pharmaceutical industry
… to contain raw materials and semi-products in pharmaceutical company ABC. Due to the high price of an IBC, company ABC sought to minimize the number of IBCs needed to support the production of four separate products. In this project, five IBCs drivers that affect or determine the number of IBCs …
-
Achieving business and operational excellence in the pharmaceutical industry
Historically the pharmaceutical industry has been highly profitable. However, the increasing regulatory requirements, bargaining power of buyers, and drug failures together with the threat of biosimilars and decreasing R&D productivity are creating challenges for research driven pharmaceutical …
-
Product quality regulation and innovation in the pharmaceutical industry.
… Also, the project selection process of major pharmaceutical companies is examined in great detail. That discussion, and some econometric tests of hypotheses generated, clearly demonstrates that in order to predict how firms will respond to changes in environmental factors affecting …
-
Business models for information commons in the pharmaceutical industry
The pharmaceutical industry needs new modes of innovation. The industry's innovation system - based on massive investments in R&D protected by intellectual property rights - has worked well for many years, providing incentives for pharmaceutical firms to invest in developing drugs across a wide …
-
Analysis of global channel costs for the pharmaceutical industry
The pharmaceutical industry creates products which often have more than one supply chain channel, defined as a route through the supply chain network from sourcing to the end market. Each channel's specific cost characteristics are important to the pharmaceutical industry's ability to maintain …
-
Is the pharmaceutical industry ready for value based procurement?
… in huge healthcare markets such as the pharmaceutical industry. To sustain shareholder value, as a result of these changing price structures, Novartis sees a need to reassess its sourcing and procurement strategies, assessing the feasibility of value based procurement, through staged …
-
Strategic Entry Deterrence In the Pharmaceutical Industry: Revisiting Product Proliferation
<p>The pharmaceutical market has become much more competitive since the Hatch-Waxman Act of 1984, as almost all drugs experience generic entry after patent protection lapses. This paper updates a hypothesis presented in a current paper by Ellison on the existence entry-deterrence motives for …
-
Research expenditures, regulation, and innovation in the ethical pharmaceutical industry
Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Economics, 1984.
-
Japanese government policy to innovative R&D in pharmaceutical industry
Thesis (M.S.)--Massachusetts Institute of Technology, Dept. of Civil and Environmental Engineering, 1994.
Page 1 of 19